Search research articles
Contact Us
Filters
Showing results (61-70 of 119) with videos related to
Page
of 12
Sort By:
The New England Journal of Medicine
|
October 19, 2017
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
Dafna Gladman, William Rigby, Valderilio F Azevedo, et al.
Joint Bone Spine
|
March 27, 2021
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action
Jordi Gratacós, Frank Behrens, Laura C Coates, et al.
Annals of the Rheumatic Diseases
|
March 4, 2022
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis
Philip J Mease, Atul A Deodhar, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)
|
November 3, 2021
Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial
Frank Behrens, Philipp Sewerin, Eugenio de Miguel, et al.
RMD Open
|
January 4, 2023
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up
Michaela Koehm, Sarah Ohrndorf, Ann C Foldenauer, et al.
BMJ Open
|
February 14, 2026
Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA)
Klaus Krueger, Frank Behrens, Jan Brandt-Juergens, et al.
Rheumatology and Therapy
|
August 5, 2022
Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial
Philip J Mease, Herbert Kellner, Akimichi Morita, et al.
Clinical Rheumatology
|
September 13, 2021
Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52
Frank Behrens, Soyi Liu Leage, Christophe Sapin, et al.
Arthritis Research & Therapy
|
January 24, 2019
The need for comparative data in spondyloarthritis
Ernest Choy, Xenofon Baraliakos, Frank Behrens, et al.
Journal of the American Academy of Dermatology
|
August 29, 2013
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
Philip J Mease, Dafna D Gladman, Kim A Papp, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 119) with videos related to
Sort By:
Page
of 12
The New England Journal of Medicine
|
October 19, 2017
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
Dafna Gladman, William Rigby, Valderilio F Azevedo, et al.
Joint Bone Spine
|
March 27, 2021
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action
Jordi Gratacós, Frank Behrens, Laura C Coates, et al.
Annals of the Rheumatic Diseases
|
March 4, 2022
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis
Philip J Mease, Atul A Deodhar, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)
|
November 3, 2021
Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial
Frank Behrens, Philipp Sewerin, Eugenio de Miguel, et al.
RMD Open
|
January 4, 2023
Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up
Michaela Koehm, Sarah Ohrndorf, Ann C Foldenauer, et al.
BMJ Open
|
February 14, 2026
Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA)
Klaus Krueger, Frank Behrens, Jan Brandt-Juergens, et al.
Rheumatology and Therapy
|
August 5, 2022
Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial
Philip J Mease, Herbert Kellner, Akimichi Morita, et al.
Clinical Rheumatology
|
September 13, 2021
Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52
Frank Behrens, Soyi Liu Leage, Christophe Sapin, et al.
Arthritis Research & Therapy
|
January 24, 2019
The need for comparative data in spondyloarthritis
Ernest Choy, Xenofon Baraliakos, Frank Behrens, et al.
Journal of the American Academy of Dermatology
|
August 29, 2013
Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
Philip J Mease, Dafna D Gladman, Kim A Papp, et al.
Page
of 12